James A Foulds

Aug 25, 2023 | journal.nzma.org.nz | Ben Beaglehole |James A Foulds |Roger Mulder

Open AccessView Article PDFExisting treatments for depression have limitations, including side effects and inadequate response rates. Thus, the recent interest in new treatments such as ketamine and psychedelic medications is not surprising. The use of psychedelics such as psilocybin for depression has been much hyped, but the evidence base for ketamine is more robust.